Representative before the EPO

Technology company logo thumb
no operation time available
4 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
3 offices
Technology Company

Representative before the EPO

Research organisation logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Employment test 501 - 1000 employees
Company dna olswang llp
operating since 1981
1189.66
Headquarter in London and 9 offices
active in Legal Services and IP Consulting

We have observed 1 EP application Andrew Farquharson has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after October 11, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12749372

METHODS OF DETECTING ANEUPLOIDY IN HUMAN EMBRYOS

IPC classification:
A61K 35/54, A61K 35/48, G01N 33/48
Agent:
CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Andrew Farquharson, Olswang
Status:
The patent has been granted

Please Sign in to use this feature